The CMS 80/20 Rule: What It Means for Medicaid Home Care Agency Valuations

The CMS Medicaid Access Rule — published in April 2024 and commonly referred to as the “80/20 rule” — is the single most consequential federal regulation affecting Medicaid home care agency valuation in a generation. For any agency with meaningful Medicaid HCBS revenue, the rule reshapes the cost structure, the sustainable EBITDA margin, and the way private equity and strategic buyers evaluate the asset.

This guide explains what the rule actually requires, which agencies are exposed, how it changes the valuation math, and what sellers should be doing now if they expect to transact within the implementation window.

---

What the 80/20 Rule Actually Says

The rule, formally titled Ensuring Access to Medicaid Services, requires that at least 80% of Medicaid payments for three specific service categories be spent on compensation for direct care workers:

1. Homemaker services
2. Home health aide services
3. Personal care services

These services must be delivered under Medicaid Home and Community-Based Services (HCBS) authorities — primarily 1915(c) waivers, 1915(i), 1915(j), 1915(k), and section 1115 demonstrations that include HCBS.

“Compensation” in the rule is defined broadly to include:

• Wages and salary
• Benefits (health insurance, retirement contributions, paid time off)
• Employer payroll taxes (FICA, FUTA, SUTA)
• Workers’ compensation premiums

What it excludes from the 80% threshold is the conventional agency profit-and-overhead bucket: administrative salaries, training (beyond direct staff time), recruiting, billing, scheduling, rent, technology, insurance other than workers’ comp, and operating margin.

What is Not Covered

The rule does not apply to:

• Medicare-certified home health (PDGM)
• Hospice
• Private pay non-medical home care
• Pediatric Private Duty Nursing under EPSDT or non-HCBS state plan authorities
• Skilled nursing visits billed under Medicaid state plan rather than HCBS
• Self-directed care models (with limited exceptions)

This scope distinction matters enormously for valuation, because it means a multi-line agency’s exposure is determined by the share of revenue inside the in-scope HCBS service codes — not by total Medicaid revenue.

---

Implementation Timeline

Full enforcement of the 80% compensation threshold phases in over six years from the rule’s effective date. Earlier-phase requirements include:

• Reporting infrastructure: states must build the data collection systems to track agency-level compensation ratios
• Interested parties advisory groups: states must convene stakeholder bodies including beneficiaries, providers, and direct care workers
• Rate transparency: states must publish payment rates for HCBS services
• Compensation ratio reporting: agencies will be required to report compensation as a percentage of HCBS payments

The compensation threshold itself becomes binding at the end of the implementation window. By that point, a non-compliant agency would either need to reach the 80% threshold or risk being unable to participate in HCBS programs in that state.

State implementation is not uniform. Some states are building reporting and rate adequacy review faster than others. A few states are exploring exemption pathways for small agencies, hardship cases, or specific geographies — but the federal floor is the federal floor, and structural exemptions are limited.

---

Why the Rule Compresses Sustainable EBITDA

To understand the valuation impact, walk through the unit economics.

Pre-Rule Baseline

A typical Medicaid HCBS personal care agency operating at scale historically allocated payments roughly as follows:

• Direct caregiver wages and taxes: 65–72% of revenue
• Caregiver benefits: 2–5% of revenue
• Administrative overhead (office staff, scheduling, recruiting, billing, compliance, rent, technology): 12–18%
• EBITDA margin: 8–18%, depending on state, scale, and operating efficiency

In this structure, the compensation ratio (wages + taxes + benefits) typically lands somewhere between 70% and 78% in well-run agencies, and lower in weaker ones.

Post-Rule Math

To hit 80% compensation, an agency operating at a 72% compensation ratio must move 8 percentage points of revenue from overhead-and-margin into caregiver compensation.

Three things can happen in response:

1. State rates rise to accommodate the new compensation floor. Some states will adjust rates upward, but rate-setting moves slowly and unevenly, and Medicaid budgets are politically constrained.
2. Overhead is cut through technology investment, scale efficiencies, and reduced administrative spend. This is real but limited — there is a floor below which compliance, scheduling, and billing cannot be cut without operational risk.
3. EBITDA margin compresses to absorb the gap.

In practice, most agencies will see some combination of all three. But the net effect for a typical Medicaid HCBS agency is a 2–6 percentage point compression in sustainable EBITDA margin, even after assuming partial rate relief and overhead optimization.

What That Does to Enterprise Value

Enterprise value moves on two axes: EBITDA (the dollar amount) and the multiple applied to it.

Margin compression hits the EBITDA dollar directly. An agency generating $20M of HCBS revenue at a 12% EBITDA margin produces $2.4M of EBITDA. Compress the margin to 8% and EBITDA drops to $1.6M — a 33% reduction in the dollar number that gets multiplied.

Buyers may also compress the multiple for Medicaid-heavy agencies whose compensation ratios are not yet compliant, because the buyer is underwriting the risk of further margin compression post-close. A pre-rule 5.5× multiple on a Medicaid-heavy agency may become 4.5× post-rule, layered on top of lower EBITDA.

The combined effect — lower EBITDA times lower multiple — can reduce enterprise value by 35–50% for a heavily Medicaid-exposed agency that has not adjusted its cost structure.

---

How Buyers Are Evaluating 80/20 Risk in Diligence

Sophisticated PE and strategic buyers have already integrated the rule into their diligence playbook for any agency with Medicaid HCBS exposure. Expect the following:

1. Compensation Ratio Calculation by Service Line

Buyers will reconstruct your compensation ratio specifically for in-scope HCBS service codes — not blended across your full book. They will isolate:

• HCBS personal care, homemaker, and aide revenue
• Direct caregiver wages, payroll taxes, benefits attributable to those service hours
• The resulting ratio expressed as a percentage

If your reported ratio is 73%, the buyer is modeling the path to 80% and adjusting their offer accordingly.

2. State-Specific Rate Adequacy Analysis

Buyers will evaluate whether the states you operate in have published rate methodologies that will support 80% compensation at sustainable margins. States with chronic rate inadequacy (rates set well below the actual cost of providing care at compliant compensation) will be discounted heavily.

Operating in states with strong rate-setting transparency, recent rate increases, or active legislative attention on HCBS adequacy is now a meaningful valuation driver.

3. Payer Mix Sensitivity Modeling

Agencies with concentrated HCBS exposure (e.g., 70%+ of revenue from in-scope HCBS codes) face the full force of the rule. Agencies with diversified payer mixes — meaningful private pay, Medicare-certified, MLTSS skilled nursing, or out-of-scope Medicaid services — have natural insulation, and buyers will pay for that insulation.

4. Technology and Operational Efficiency

Buyers will look at your back-office cost structure as a percentage of revenue. Agencies running modern EVV-integrated scheduling, automated billing, and lean recruiting infrastructure are positioned to operate profitably at lower overhead percentages — exactly what the rule rewards. Agencies with bloated administrative cost structures will be discounted.

5. Self-Directed Care Mix

Self-directed services have specific treatment under the rule (with some exemptions and lighter compensation requirements depending on state implementation). Agencies with meaningful fiscal intermediary or self-directed program revenue may have a different exposure profile than pure agency-directed providers.

---

Strategic Implications for Sellers

If You Are Medicaid-Heavy and Planning to Sell Within 24 Months

You are selling into a market where buyers are pricing in the compression. Three priorities:

1. Get your compensation ratio defensible. Calculate it now, by service line, and understand exactly how far you are from 80%. If you are at 76–78%, the gap is closeable and your story is strong. If you are at 68–70%, you have a credibility problem in diligence.
2. Document the path to compliance. Even if you are not yet at 80%, a credible plan — rate increases pending in your state, wage adjustments scheduled, benefits expansion in progress — is materially better than no plan.
3. Diversify payer mix where possible. Adding private pay, MLTSS skilled, or Medicare-certified lines reduces the concentration risk and improves your blended valuation.

If You Have Time (3–5 Year Horizon)

The strategic playbook is more aggressive:

• Restructure cost base proactively. Move toward the 80% threshold before you have to. Buyers reward agencies that have already absorbed the compression and demonstrated sustainable margins at the new structure.
• Invest in technology that reduces overhead percentage. EVV-integrated platforms, automated scheduling and billing, AI-assisted recruiting and retention.
• Geographic concentration in rate-adequate states. Exit or de-emphasize markets with chronic rate inadequacy. Concentrate in states with active rate-setting transparency.
• Expand into out-of-scope service lines. Private pay, Medicare-certified home health, MLTSS skilled, pediatric PDN, behavioral health — each diversifies away from 80/20 exposure and adds enterprise value on its own.

If You Are Considering Acquiring

The rule is also creating opportunity. Smaller agencies without the scale to absorb compression, restructure cost base, or invest in efficiency-driving technology will be motivated sellers in the implementation window. Buyers with the operating infrastructure to integrate acquired agencies into a compliant cost structure can buy at attractive multiples and create meaningful value.

---

Common Misconceptions

“The rule doesn’t apply to my state yet, so it doesn’t affect my valuation.”

It affects your valuation today, because buyers underwrite the future cost structure, not the current one. A buyer paying you a multiple in 2026 is owning the asset through full enforcement. The rule is in the model.

“My private pay and Medicare lines are unaffected, so I’m fine.”

Correct that those lines are out of scope, but if your HCBS line is a meaningful share of revenue, that share carries a different valuation profile post-rule. Buyers will not blend; they will value the in-scope and out-of-scope revenue differently.

“Rates will go up to cover the cost.”

Some states will raise rates. Many will not, or will not raise them enough. Federal rule, state-by-state implementation, state-by-state budget reality. Plan for partial relief, not full relief.

“I can hit 80% by reclassifying overhead as compensation.”

The rule’s definition of compensation is specific. Reclassification games will not survive auditor or buyer diligence.

---

What to Do Now

1. Calculate your current compensation ratio for in-scope HCBS services, by state, by program. Get the number on paper before a buyer calculates it for you.
2. Map your HCBS revenue by state and check published state implementation timelines and rate methodologies.
3. Model two to three EBITDA scenarios assuming different paths to 80%: no rate relief, partial rate relief, and full rate relief. Understand what your sustainable EBITDA looks like in each case.
4. Assess overhead reduction potential — technology investment, billing automation, scheduling efficiency — and quantify the overhead reduction you can credibly achieve.
5. Review your sale timing strategy in light of the above. For some agencies, the right answer is to sell now into the current market. For others, the right answer is to invest, restructure, and sell in 2027–2028 at a stronger compliance position.

The 80/20 rule is not an existential threat for well-run Medicaid home care agencies. It is a structural reset of the cost-and-margin profile of the industry, and the agencies that adjust thoughtfully — whether through restructuring, diversification, or strategic timing of a sale — will continue to attract strong buyer interest. The agencies that do nothing and hope for the best will see compression in both EBITDA and multiple.

If you would like to talk through how the rule affects your specific agency’s valuation and exit strategy, contact us for a confidential conversation.